Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.
Stridex Sensitive Salicylic Acid .5 g/100mL Liquid — NDC 10157-1007-1 (Billing 10157-1007-01)
by Blistex Inc · 1 JAR in 1 CARTON / 55 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR
This is a package of Stridex Sensitive Salicylic Acid .5 g/100mL Liquid from Blistex Inc, marketed since Dec 2012 and currently FDA-listed. It is the main listing for this product, which comes in 4 package sizes.
NDC 10157-1007-01
🏷️ FDA NDC (as labeled)
10157-1007-1
billing pads the package segment with a zero
This package
Contains2 mL in 1 applicator
Pack sizes4 compare ↓
Main listing for product 10157-1007 · Also comes in:
2 mL 10157-1007-2
2 mL 10157-1007-3
2 mL 10157-1007-4
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
NDC database record
One package, one record: these facts belong to NDC 10157-1007-1 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 10157 labeler · 1007 product · 1 package
- Package marketed since
- Dec 1, 2012
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2026
- Barcode (UPC-A, from the NDC)
- 3 1015710071 4
- FDA record last changed
- Jul 24, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
FDA NDC (as labeled)
10157-1007-1
Product NDC
10157-1007
11-digit billing NDC
10157100701
NCPDP billing unit
EA — each (per item)
UNII
O414PZ4LPZ
Application #
M006
SPL Set ID
843d3424-bd6c-44aa-976b-63c9da15014e
DEA schedule
Non-controlled
Marketing category
OTC MONOGRAPH DRUG
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2012-12-01
Route
TOPICAL
Dosage form
LIQUID
Substance
SALICYLIC ACID
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
GPI-14
90750030004320
GPI class
Stri-Dex Sensitive Skin
GCN Seq No
005763
GCN
22700
HICL code
002465
Ingredient (HICL)
Salicylic Acid
HIC1 code
L
Therapeutic class — broad (HIC1)
Skin/Subcutaneous Tissue
HIC2 code
L5
Therapeutic class — intermediate (HIC2)
Keratolytics/Keratoplastics
HIC3 code
L5A
Therapeutic class — specific (HIC3)
Keratolytics
AHFS code
84:28.00.00
AHFS class
Keratolytic Agents
FDB label name
STRI-DEX SENSITIVE SKIN PAD
FDB brand name
Stri-Dex
Legend status
O — Over-the-counter (OTC) drug or device
Quick answers
- GSN (GCN sequence number): 005763
- GCN: 22700
- GPI-14 (Medi-Span): 90750030004320
- HICL (First Databank): 002465
- AHFS class code: 84:28.00.00
Why two NDCs?
The FDA registers this code as 10157-1007-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 10157-1007-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
- RxNorm (NLM RxNav) · catalog refreshed Oct 1, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Oct 8, 2026
Clinical
Label name STRI-DEX SENSITIVE SKIN PAD Ingredient Salicylic Acid
📖 About the active ingredient: Salicylic Acid MedlinePlus · NLM
General information about the ingredient itself — the description of this specific product follows below.
Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or b...
Read the full MedlinePlus article ↗🧪 What is this product?
Stridex Sensitive is a topical liquid containing salicylic acid, marketed as an over-the-counter skin care product under FDA's OTC monograph rules. Salicylic acid is commonly used in acne and blemish treatment products where it functions as a keratolytic agent to help exfoliate the outer skin layer. This product is applied directly to the skin surface as part of a daily cleansing or treatment routine.
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
- MedlinePlus (NLM) · refreshed Oct 8, 2026
- FDA label on DailyMed · label index refreshed Oct 8, 2026
💬 Questions about Salicylic Acid?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
ℹ️
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Sep 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Oct 8, 2026
- CMS Part D plan pricing files · refreshed Sep 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 10157-1007-01 You're viewing this Main listing | 1 JAR in 1 CARTON / 55 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR | 2012-12-01 | — | Active |
| 10157-1007-02 10157-1007-2 | 1 JAR in 1 CARTON / 70 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR | 2012-12-01 | — | Active |
| 10157-1007-03 10157-1007-3 | 1 JAR in 1 CARTON / 90 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR | 2012-12-01 | — | Active |
| 10157-1007-04 10157-1007-4 | 1 JAR in 1 CARTON / 110 APPLICATOR in 1 JAR / 2 mL in 1 APPLICATOR | 2012-12-01 | — | Active |
Pack size FAQ
What quantity is in this package?
This package is listed by the FDA — 1 jar in 1 carton / 55 applicator in 1 jar / 2 ml in 1 applicator.
What NDC number is used to bill for this package of Stridex Sensitive Salicylic Acid .5 g/100mL Liquid?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| In the Clear Acne Serum .5 g/100mL 69366-0414-31 | The | 1 bottle | — | — | FDA listed | — |
| So Totally Clean Deep Pore Cleanser .5 g/100mL 70626-0104-21 | ASPIRE | 200 ml | — | — | FDA listed | — |
| Caring Mill Acne Clearing Cleanser .5 g/100mL 81522-0100-01 | FSA | 250 ml | — | — | FDA listed | — |
| Clear Smart Clarifying Cleansing Foam .5 g/100mL 68828-0244-01 | Distribuidora | 125 ml | — | — | FDA listed | — |
| Stridex Sensitive .5 g/100mLthis 10157-1007-01 | Blistex | 1 jar | — | — | FDA listed | — |
| Clear Smart Clear Complexion Toner .5 g/100mL 68828-0289-01 | Distribuidora | 200 ml | — | — | FDA listed | — |
| Clarifying Cleanser .5 g/100mL 70381-0128-02 | Murad, | 1 tube | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- FDA Orange Book · refreshed Oct 3, 2026
- CMS NADAC weekly file
Availability & generic status
🏛️
2012
On the market since
Dec 2012
📍
2026
Currently FDA-listed
14 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
- FDA Orange Book · refreshed Oct 3, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII ZY81Z83H0X
Aloe vera leaf is a plant extract derived from the aloe plant. It is used in medicines as a natural moisturizer and skin-soothing agent in topical formulations.
-
UNII Q7AO2R1M0B
Ammonium lauryl sulfate is a mild detergent and foaming agent derived from plant oils. It helps mix water and oil-based ingredients together and creates a light foam in topical formulations like shampoos and cleansers.
-
UNII 4FZY6L6XCM
A synthetic compound derived from xylenol and ammonia. It functions as a solubilizing agent and surfactant, helping dissolve poorly water-soluble active ingredients and improve their absorption in the body.
-
UNII 2968PHW8QP
A weak organic acid derived from citrus fruits or made through fermentation. It works as a buffer to control pH, a preservative to extend shelf life, and a flavoring agent in medications.
-
UNII BYR0546TOW
DMDM hydantoin is a preservative chemical used to prevent the growth of bacteria and fungi in medicines. It helps keep the product safe and stable throughout its shelf life.
-
UNII MP1J8420LU
A salt derived from edetic acid that binds to trace metals in medicines. It serves as a chelating agent and preservative to prevent metal-catalyzed breakdown of the drug and extend shelf life.
-
UNII UDA30A2JJY
A plant extract from witch hazel used as an astringent and skin-conditioning agent in topical formulations. It helps tone and soothe the skin while functioning as a natural preservative.
-
UNII L7T10EIP3A
A cooling compound from mint plants used as a flavoring agent and to create a fresh sensation in medicines. It helps mask bitter tastes and improve how the product feels in the mouth.
-
UNII 4AAN25P8P4
A synthetic liquid derived from propylene glycol and cetyl alcohol, used as an emulsifier and solubilizer to help mix oil and water-based ingredients and keep the medicine uniform throughout.
-
UNII 91MBZ8H3QO
Sodium borate is an inorganic salt compound used in medicines as a buffer to help maintain a stable pH level, and sometimes as a mild preservative or cleansing agent in topical formulations.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
11 inactive ingredients listed in the exact product block matched to this NDC.
The official label also statesaloe barbadensis leaf juice, ammonium lauryl sulfate, ammonium xylenesulfonate, citric acid, DMDM hydantoin, fragrance, hamamelis virginiana (witch hazel) extract, menthol, PPG-5-Ceteth-20, purified water, simethicone, sodium borate, tetrasodium EDTA.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Oct 8, 2026
- FDA openFDA NDC Directory · synced Oct 8, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
Manufacturer & labeler
LabelerBlistex Inc
FDA applicationM006 (OTC MONOGRAPH DRUG)
Labeler code10157
First marketedDec 2012
Product typeHuman Otc Drug
Portfolio15 products on file
More NDCs from Blistex Inc labeler code 10157
- Stridex Maximum SALICYLIC ACID 2 g/100mL Liquid NDC 10157-1006-1
- Blistex Medicated Lip Balm DIMETHICONE, OCTINOXATE, and OCTISALATE 2 g/100g; 6.6 g/100g; 4.4 g/100g Stick NDC 10157-1119-1
- Blistex Medicated Mint Balm DIMETHICONE, OCTINOXATE, and OCTISALATE 2 g/100g; 6.6 g/100g; 4.4 g/100g Stick NDC 10157-1120-1
- Blistex Medicated Berry Balm Dimethicone, Octinoxate, and Octisalate 2 g/100g; 6.6 g/100g; 4.4 g/100g Stick NDC 10157-1121-1
- Deep Renewal Broad Spectrum dimethicone, avobenzone, homosalate, and octisalate 2 g/100g; 3 g/100g; 9 g/100g; 4.4 g/100g Stick NDC 10157-1170-1
- Blistex Five Star Lip Protection Broad Spectrum Homosalate, Octisalate, Avobenzone, and Dimethicone 15 g/100g; 5 g/100g; 3 g/100g; 2 g/100g Stick NDC 10157-1171-1
- Repair and Protect Petrolatum 45 g/100g Stick NDC 10157-1189-1
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
- FDA openFDA NDC Directory · synced Oct 8, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
📄 Do Not Use
📄 When Using This Product
📄 Keep Out of Reach of Children
📄 Package Label / Principal Display Panel
🎯 Indications and Usage ▾
Uses for the treatment and management of acne reduces the number of acne pimples and blackheads and allows the skin to heal helps to prevent new acne pimples from forming
⏱️ Dosage and Administration ▾
Directions cleanse the skin thoroughly before applying medication use the pad to wipe the entire affected area repeat with a clean pad as necessary to remove remaining traces of dirt because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily as needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day do not leave pad on skin for an extended period of time keep away from eyes, lips and other mucous membranes
⚠️ Warnings ▾
Warnings For external use only Allergy alert do not use this product if you have a known allergy to salicylic acid When using this product using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor. Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
🧪 Active Ingredient ▾
Active ingredient Salicylic acid 0.5% (w/w)
🧪 Inactive Ingredients ▾
Inactive ingredients aloe barbadensis leaf juice, ammonium lauryl sulfate, ammonium xylenesulfonate, citric acid, DMDM hydantoin, fragrance, hamamelis virginiana (witch hazel) extract, menthol, PPG-5-Ceteth-20, purified water, simethicone, sodium borate, tetrasodium EDTA.
🎯 Purpose ▾
Purpose Acne medication
📄 Do Not Use ▾
do not use this product if you have a known allergy to salicylic acid
📄 When Using This Product ▾
When using this product using other topical acne medication at the same time or immediately following use of this product may increase dryness or irritation of the skin. If this occurs, only one medication should be used unless directed by a doctor.
📄 Keep Out of Reach of Children ▾
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL - 90 Pad Jar Carton NDC 10157-1007-2 SINGLE-STEP ACNE CONTROL ™ ALCOHOL FREE STRIDEX ® SALICYLIC ACID 0.5% W/W ACNE MEDICATION SENSITIVE WITH ALOE 90 SOFT TOUCH PADS Principal Display Panel - 90 Pad Jar Carton
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
Medicare Part D spend CMS · PART D · 2026 (Q1)
Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.
Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Stridex Sensitive (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 37%
Female · 63%
Unknown · 0%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
About this NDC listing & data coverage
Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Blistex Inc. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 1 jar (10157-1007-02), 1 jar (10157-1007-03), 1 jar (10157-1007-04). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Blistex Inc is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.